Previous studies have shown that YKL-40 tissue expression may serve as a useful prognostic biomarker for solid tumors, such as glioma, ovarian cancer, breast cancer, lung cancer, urologic neoplasm, thyroid carcinoma, and gastric cancer [8,9,10,11,12,13,14]. The gene discussed is CHI3L1; the disease is ovarian cancer.